Deregulation of apolipoprotein C2 gene in cancer: A potential metabolic vulnerability

Clin Transl Med. 2021 Jun;11(6):e406. doi: 10.1002/ctm2.406.

Authors

Yuqiao Liu¹, Yiting Meng¹, Tian Zhang², Houda Alachkar^{1

3}

Affiliations

¹ Titus Family Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, California, USA.
² Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
³ USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.

No abstract available

Keywords: APOC2; cancer; lipid metabolism.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Apolipoprotein C-II / genetics*
Apolipoprotein C-II / metabolism*
Biomarkers, Tumor / analysis*
Biomarkers, Tumor / genetics
Biomarkers, Tumor / metabolism
Case-Control Studies
DNA Methylation*
Gene Expression Regulation, Neoplastic*
Humans
Neoplasms / genetics
Neoplasms / metabolism
Neoplasms / pathology*
Prognosis
Survival Rate
Tumor Cells, Cultured

Substances

Apolipoprotein C-II
Biomarkers, Tumor